Project Details
Description
A multi-center, randomized, double-blind, 52-week study to assess the safety of QVA149 compared to QAB in patients with Chronic Obstructive Pulmonary Disease (COPD) who have moderate to severe airflow limitation
| Status | Finished |
|---|---|
| Effective start/end date | 9/1/12 → 12/31/14 |
Funding
- NOVARTIS PHARMACEUTICALS CORPORATION
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.